Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound

Coverage of amniotic/placental-derived product injections/applications for non‑wound musculoskeletal indications is determined by Proposed LCD DL39877 and services that do not meet its reasonable-and-necessary criteria are not covered (and any same-day associated injection/application will be denied). Claims must follow the LCD’s criteria and coding guidance (use appropriate modifiers for non-covered services) and be supported by complete, legible medical records with patient identifiers, dates of service, provider signature, and documentation justifying the ICD‑10 and CPT/HCPCS codes.